Ductal Carcinoma In Situ



Ductal Carcinoma In Situ






4.1 CRIBRIFORM ATYPICAL DUCTAL HYPERPLASIA VS. LOW-GRADE DUCTAL CARCINOMA IN SITU

















































Cribriform Atypical Ductal Hyperplasia (ADH)


Low-Grade Ductal Carcinoma In Situ (DCIS)


Age


Adult women


Adult women, usually older than 50 y


Location


Anywhere in the breast


Anywhere in the breast


Imaging findings


Calcifications, or incidental finding


Calcifications, rarely mass-forming


Etiology


Unknown


Unknown


Histology




  1. Terminal duct lobular unit contains a uniform proliferation of small, bland cells with distinct cell borders and even cell placement but process incompletely occupies the involved spaces (Figs. 4.1.1, 4.1.2, 4.1.3, 4.1.4, 4.1.5)



  2. Rigid architecture consisting of cribriform spaces or mixed solid and cribriform areas (Figs. 4.1.2, 4.1.3, 4.1.4)



  3. Subtle microrosettes may be present (Fig. 4.1.5)



  4. Limited extent, usually confined to the terminal duct lobular unit and measuring less than 2 mm (Fig. 4.1.1)




  1. Terminal duct lobular units, as well as true ducts contain a uniform proliferation of small bland cells (Figs. 4.1.6, 4.1.7, 4.1.8, 4.1.9, 4.1.10)



  2. Complete involvement of at least two adjacent spaces, equivalent to a linear extent of at least 3 mm (Figs. 4.1.6, 4.1.7, 4.1.8)



  3. Cell borders are distinct, and cells are evenly placed (Fig. 4.1.9)



  4. Rigid architecture with cribriform or micropapillary patterns most common (Figs. 4.1.7, 4.1.8, 4.1.9, 4.1.10); solid growth pattern may contain microrosettes



  5. True duct involvement often (Figs. 4.1.6 and 4.1.7)


Special studies


None, CK5/6 usually not expressed


None; CK5/6 usually not expressed; estrogen receptor (ER) routinely assessed to predict response to adjuvant endocrine therapy; multigene assay may predict which patients may be spared radiation


Genetic abnormalities


Loss of 16q, 17p


Loss of 16q, 17p


Treatment


Excision if detected in core biopsy, mammographic follow-up ± antiestrogen therapy


Complete excision with negative margins, ± adjuvant radiation, ± antiestrogen therapy; sentinel lymph node biopsy not indicated


Clinical implication


Moderately increased risk of later cancer development (4-5×); risk is bilateral


Development of invasive carcinoma in approximately 30% of cases if incompletely excised; with complete excision recurrence rate is approximately 5%-8% without radiation; when limited in extent recurrence rate <5%








Figure 4.1.1 ADH: A lobular unit is expanded by a proliferation of cells showing rigid architecture.






Figure 4.1.2 Several acini are partially populated by monotonous cells in ADH; note residual normally polarized cells at periphery of spaces and occasional irregularly shaped secondary spaces.






Figure 4.1.3 Uniform, evenly placed cells are present centrally in the involved spaces (right of center), while the cells at the periphery of the acini lack uniformity and maintain normal polarity, qualifying as ADH.






Figure 4.1.6 Low-grade DCIS. Three lobular units and ducts are populated by uniform cells with rigid architecture.






Figure 4.1.7 In addition to cytology and architecture, the extent of the proliferation, including involvement of true ducts, qualifies as DCIS.






Figure 4.1.8 Secretory material should not be misinterpreted as necrosis in this example of low-grade DCIS.







Figure 4.1.4 Despite cellular monotony, the peripheral secondary spaces are irregular in this example of ADH.






Figure 4.1.5 Uniform cells form microrosettes in this example of ADH.






Figure 4.1.9 The involved spaces are contiguous and completely replaced by the atypical cells, underscoring the importance of the extent of involvement in making the determination of DCIS.






Figure 4.1.10 Low-grade DCIS: Uniform cell population with distinct cell borders forms crisp secondary spaces.



4.2 MICROPAPILLARY ATYPICAL DUCTAL HYPERPLASIA VS. MICROPAPILLARY DUCTAL CARCINOMA IN SITU

















































Micropapillary ADH


Micropapillary DCIS


Age


Adult women


Adult women


Location


Anywhere in the breast


Anywhere in the breast


Imaging findings


Calcifications or incidental finding


Calcifications, rarely mass or nipple discharge


Etiology


Unknown


Unknown


Histology




  1. Epithelial proliferation limited to partial involvement of the terminal duct lobular unit (Figs. 4.2.1, 4.2.2, 4.2.3, 4.2.4, 4.2.5)



  2. Bulbous micropapillary projections composed of evenly placed, uniform cells (Figs. 4.2.4 and 4.2.5); second population of normally polarized cells remains



  3. Micropapillae extend from the basement membrane and lack fibrovascular cores (Figs. 4.2.4 and 4.2.5)




  1. Micropapillary proliferation involving several expanded lobular units and ducts (Figs. 4.2.6, 4.2.7, 4.2.8, 4.2.9, 4.2.10)



  2. Proliferation of uniform cells evenly placed within bulbous micropapillae (Figs. 4.2.8, 4.2.9, 4.2.10)



  3. Micropapillae lack fibrovascular cores and extend into lumen from basement membrane (Figs. 4.2.8, 4.2.9, 4.2.10)



  4. May be of low, intermediate, or high nuclear grade, although differential diagnostic partner with ADH is low-grade DCIS (Fig. 4.2.10)



  5. May be present in a patchy distribution within individual lobular units; however, numerous contiguously involved spaces support a diagnosis of micropapillary DCIS (Fig. 4.2.6)


Special studies


None; CK5/6 is usually not expressed


None; CK5/6 usually not expressed; ER expression routinely assessed to predict response to adjuvant endocrine therapy; multigene assay may predict which patients may be spared radiation


Genetic abnormalities


Loss of 16q, 17p


Loss of 16q, 17p


Treatment


Excision if detected in core biopsy specimen; mammographic follow-up, ± antiestrogen therapy


Complete excision with negative margins, ± adjuvant radiation, ± antiestrogen therapy; sentinel lymph node biopsy not indicated. Pure micropapillary DCIS may be extensively present in the breast, requiring mastectomy.


Clinical implication


Moderately increased risk of later cancer development (4-5×); risk is bilateral


Development of invasive carcinoma in approximately 30% of cases if incompletely excised; with complete excision, recurrence rate approximately 5%-8% without radiation; recurrence rate less than 5% for low grade DCIS of limited extent








Figure 4.2.1 ADH: A core needle biopsy specimen contains an expanded lobular unit; several of the spaces contain bulbous micropapillary projections.






Figure 4.2.2 Cellular uniformity of the micropapillary projections of ADH is evident even on low power.






Figure 4.2.3 Normally polarized cells are present between the micropapillae in this example of ADH.






Figure 4.2.6 Micropapillary DCIS (low grade): Several adjacent lobular units and intervening ducts contain a proliferation of micropapillae, with a “shaggy” appearance at low power.






Figure 4.2.7 This example of micropapillary DCIS also involves papillomas, explaining the presence of papillary projections with fibrovascular cores.






Figure 4.2.8 The micropapillae of DCIS are bulbous, with even cell placement; the architectural complexity of the proliferation is evidenced by the presence of seemingly unattached cell clusters within lumens.







Figure 4.2.4 Micropapillae of ADH lack fibrovascular cores.






Figure 4.2.5 ADH is composed of a uniform population of cells that are evenly distributed within the micropapillae, which extend to the basement membrane rather than being “perched” on the surface of the luminal epithelial layer.






Figure 4.2.9 Cells forming the micropapillae are similar to the adjacent cells lining the expanded spaces in this example of DCIS.






Figure 4.2.10 The micropapillae of DCIS are bulbous and are attached to the basement membrane.



4.3 MICROPAPILLARY DUCTAL CARCINOMA IN SITU VS. USUAL HYPERPLASIA RESEMBLING GYNECOMASTIA

















































Micropapillary DCIS


Usual Hyperplasia Resembling Gynecomastia


Age


Adult women


Adult women


Location


Anywhere in the breast


Anywhere in the breast


Imaging findings


Calcifications, rarely mass or nipple discharge


Calcifications, often incidental finding


Etiology


Unknown


Unknown


Histology




  1. Micropapillary proliferation involving several expanded lobular units and ducts (Figs. 4.3.1, 4.3.2, 4.3.3, 4.3.4, 4.3.5, 4.3.6)



  2. Proliferation of uniform cells evenly placed within bulbous micropapillae (Figs. 4.3.5 and 4.3.6)



  3. Micropapillae lack fibrovascular cores and extend into the lumen from the basement membrane (Figs. 4.3.5 and 4.3.6)



  4. May be of low, intermediate, or high nuclear grade



  5. May be present in a patchy distribution within individual lobular units; however, involvement of numerous spaces supports a diagnosis of micropapillary DCIS (Figs. 4.3.1 and 4.3.2)




  1. Epithelial proliferation within terminal duct lobular units (Figs. 4.3.7, 4.3.8, 4.3.9, 4.3.10, 4.3.11, 4.3.12)



  2. Cellular variability and indistinct cell borders characteristic



  3. Small bland cells with pyknotic nuclei form tapering, “pinched-appearing” micropapillary projections (Figs. 4.3.10, 4.3.11, 4.3.12)



  4. Micropapillary projections appear “stuck on” luminal layer (Fig. 4.3.12)


Special studies


None; CK5/6 usually not expressed; ER expression routinely assessed to predict response to adjuvant endocrine therapy following a diagnosis of DCIS; multigene assay may predict which patients may be spared radiation


None; CK 5/6 may show patchy expression


Genetic abnormalities


Loss of 16q, 17p


None


Treatment


Complete excision with negative margins, ± adjuvant radiation, ± antiestrogen therapy; sentinel lymph node biopsy not indicated; pure micropapillary DCIS may be extensively present in the breast, requiring mastectomy


Excision not necessary when detected in core biopsy specimen


Clinical implication


Development of invasive carcinoma in approximately 30% of cases if incompletely excised; with complete excision, recurrence rate approximately 5%-8% without radiation; recurrence rate less than 5% for low grade DCIS of limited extent


Slightly increased risk of later cancer development (1.5×); risk is bilateral, but of insufficient magnitude to affect patient management








Figure 4.3.1 Several adjacent lobular units are expanded by an epithelial proliferation that forms micropapillae, imparting a “shaggy” appearance to the spaces in DCIS.






Figure 4.3.2 Bulbous micropapillae of DCIS project from the basement membrane and some appear unattached within the lumen.






Figure 4.3.3 Some of the micropapillae are fused in this example of DCIS.






Figure 4.3.7 Hyperplasia resembling gynecomastia forms a nodule of fibrous stroma containing an epithelial proliferation.






Figure 4.3.8 Several lobular units and a true duct show an epithelial proliferation forming micropapillary structures in hyperplasia resembling gynecomastia.






Figure 4.3 9 Stromal changes accompany the epithelial hyperplasia; intralobular stroma is fibrous, similar to pseudoangiomatous stromal hyperplasia.







Figure 4.3.4 Micropapillary DCIS characteristically has a patchy distribution, with some spaces partially involved by micropapillae; however, the nonmicropapillary luminal epithelium has the same cytology as the micropapillae.






Figure 4.3.5 Detached micropapillae within the lumen highlight the 3-dimensional complexity of micropapillary DCIS.






Figure 4.3.6 Micropapillae of DCIS may appear tapered near the point of attachment; however, neoplastic cells are evenly distributed around the bulbous projections. Note similarity of the lining epithelium to that forming the micropapillae.






Figure 4.3.10 Micropapillae are focally present in true ducts as well as in lobular units in hyperplasia resembling gynecomastia.






Figure 4.3.11 Hyperplasia resembling gynectomastia is characterized by cells with pyknotic nuclei peripherally arranged around micropapillae with “empty” centers.






Figure 4.3.12 In hyperplasia resembling gynecomastia, micropapillae composed of cells with pyknotic nuclei appear “stuck” on the luminal epithelium, without connection to the basement membrane. The lining epithelium shows nuclear variability.



4.4 INTERMEDIATE-GRADE DUCTAL CARCINOMA IN SITU VS. FLORID HYPERPLASIA WITHOUT ATYPIA

















































Intermediate-Grade DCIS


Florid Hyperplasia without Atypia


Age


Adult women, usually 50 y or older


Adult women


Location


Anywhere in the breast


Anywhere in the breast


Imaging findings


Calcifications, rarely mass-forming


Calcifications, rarely mass-forming often incidental


Etiology


Unknown


Unknown


Histology




  1. Terminal ducts as well as true ducts are involved by epithelial proliferation (Figs. 4.4.1, 4.4.2, 4.4.3, 4.4.4)



  2. Initial impression of nuclear overlap; however, nuclei resemble each other, without true variability (Figs. 4.4.3 and 4.4.4)



  3. Intermediate-grade nuclei that appear “frozen in place” without streaming or swirling (Figs. 4.4.3 and 4.4.4)



  4. Subtle microrosettes are frequently present (Fig. 4.4.4)




  1. Affects terminal duct lobular unit (Figs. 4.4.5, 4.4.6, 4.4.7, 4.4.8)



  2. Nuclear variability and overlap (Figs. 4.4.7 and 4.4.8)



  3. Irregular secondary spaces (Fig. 4.4.6)



  4. Indistinct cell borders (Fig. 4.4.8)


Special studies


None; CK5/6 usually not expressed; ER expression routinely assessed to predict response to adjuvant endocrine therapy; multigene assay may predict which patients may be spared radiation


None; CK5/6 is variably expressed


Genetic abnormalities


Loss of 16q, 17p


None


Treatment


Complete excision with negative margins, ± adjuvant radiation, ± antiestrogen therapy


None


Clinical implication


Development of invasive carcinoma in approximately 30% of cases if incompletely excised; with complete excision, recurrence rate approximately 5%-8% for DCIS of limited extent


Slightly increased risk of later cancer development (1.5×) in either breast; risk level insufficient to affect patient management








Figure 4.4.1 DCIS: Core needle biopsy specimen showing several lobular units and intervening ducts containing a solid epithelial proliferation with necrosis.






Figure 4.4.2 A papilloma is present (left of center), showing the same proliferation as the surrounding ducts in this example of DCIS.






Figure 4.4.3 Although there is a suggestion of nuclear streaming and swirling, cellular monotony is characteristic of DCIS.






Figure 4.4.5 A solid epithelial proliferation involves adjacent lobular units in florid hyperplasia without atypia.






Figure 4.4.6 Nuclear variability, cellular overlap, and irregular secondary spaces characterize florid hyperplasia without atypia.






Figure 4.4.7 Florid hyperplasia without atypia has irregular secondary spaces and indistinct cell borders.







Figure 4.4.4 Subtle microrosettes formed by uniform cells characterize this pattern of DCIS. The cells of adjacent microrosettes appear to overlap, but they are evenly distributed around their respective secondary spaces.






Figure 4.4.8 Nuclear variability and occasional inclusions “heliotropes” are a defining feature of florid hyperplasia without atypia.



4.5 SPINDLE CELL PATTERN DUCTAL CARCINOMA IN SITU VS. USUAL HYPERPLASIA WITHOUT ATYPIA

















































Spindle Cell Pattern DCIS


Usual Hyperplasia without Atypia


Age


Adult women, usually 50 y or older


Adult women


Location


Anywhere in the breast


Anywhere in the breast


Imaging findings


Calcifications, rarely mass-forming


Calcifications or incidental


Etiology


Unknown


Unknown


Histology




  1. Terminal ducts as well as true ducts are expanded by a solid epithelial proliferation (Figs. 4.5.1, 4.5.2, 4.5.3)



  2. Initial impression of nuclear overlap; however, cells resemble each other, without true variability (Fig. 4.5.4)



  3. Epithelial proliferation is composed of low to intermediate grade nuclei that show spindled morphology with occasional microrosettes (Figs. 4.5.5 and 4.5.6)




  1. Nuclear variability, swirling or streaming pattern, nuclear overlap



  2. Secondary spaces are peripheral and irregular.



  3. Epithelial proliferation may be solid without secondary spaces (Figs. 4.5.7, 4.5.8, 4.5.9, 4.5.10, 4.5.11)


Special studies


None; CK5/6 usually not expressed; ER expression routinely assessed to predict response to adjuvant endocrine therapy; multigene assay may predict which patients may be spared radiation


None, CK5/6 is variably expressed


Genetic abnormalities


None specific to the spindle cell pattern


None


Treatment


Complete excision with negative margins, ± adjuvant radiation, ± antiestrogen therapy; sentinel lymph node biopsy not indicated


Excision not necessary if detected on core biopsy specimen


Clinical implication


Development of invasive carcinoma in approximately 30% of cases if incompletely excised; with complete excision, recurrence rate approximately 5%-8% without radiation


Slightly increased risk of later cancer development (1.5×); insufficient to affect patient management

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 23, 2018 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Ductal Carcinoma In Situ

Full access? Get Clinical Tree

Get Clinical Tree app for offline access